Art

J-GLOBAL ID：200902142850511897   Reference number：00A0911213

Olanzapine optimal dose. Results of an open-label multicenter study in schizophrenic patients.

オランザピンの至適用量 精神分裂病患者を対象としたオープンラベル多施設研究の結果

Author (3)： ISHIGOOKA J (Kitasato Univ., Sagamihara, JPN) ,  MURASAKI M (Kitasato Univ., Sagamihara, JPN) ,  MIURA S (Kitasato Univ., Sagamihara, JPN)
Material： Psychiatry and Clinical Neurosciences  (Psychiatry Clin Neurosci)
Volume： 54  Issue： 4  Page： 467-478  Publication year： Aug. 2000 
JST Material Number： W1032A  ISSN： 1323-1316  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： *human ,...
Semi thesaurus term： benzodiazepine tranquilizer ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=00A0911213&from=J-GLOBAL&jstjournalNo=W1032A") }}

JST classification (1)： Clinical application of psychotropic drugs  (GW03110J)

Substance index (1)： Olanzapine

Reference (27)：

• MELTZER, HY. The mechanism of action of clozapine in relation to its clinical advantages. Novel Antipsychotic Drugs. 1992, 1-13
• BYMASTER, FP. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 1996, 14, 87-96
• SCHOTTE, A. Risperidone compared with new and reference antipsychotic drugs : in vitro and in vivo receptor binding. Psychopharmacology. 1996, 124, 57-73
• BYMASTER, FP. Decreased binding affinity of olanzapine and clozapine for human muscarinic receptors in intact clonal cells in physiological medium. Eur. J. Pharmacol. 2000, 390, 245-248
• BYMASTER, FP. Review of the preclinical pharmacology of olanzapine : a MARTA class antipsychotic. Jpn. J. Clin. Psychopharmacol. 1999, 2, 885-911

Terms in the title (7)： オランザピン ,  至適用量 ,  精神分裂病 ,  患者 ,  ラベル ,  施設 ,  研究